A trio of European scientists has linked subtle changes in the brain’s white matter — tissue rich in nerve cell projections — to early relapsing-remitting multiple sclerosis (RRMS), a form of the neurodegenerative disease marked by flare-ups interspersed with periods of remission. Using a specialized noninvasive imaging technique, the…
Discussion
It’s funny how multiple sclerosis (MS) has a way of silencing me. Since my diagnosis in 2016, I’ve felt as if something else has been speaking, moving, and living through me. Although I’ve been present in my own body, it often feels like I’m simply waiting on the sidelines.
Discussion
An experimental oral drug called remibrutinib outperformed the approved therapy Aubagio (teriflunomide) in reducing disease flare rates in two large, late-stage clinical trials involving people with relapsing forms of multiple sclerosis (MS). That’s according to top-line data — the studies’ first results — announced by remibrutinib’s developer…
Discussion
Patterns in how different regions of the brain are structurally organized may help distinguish people with multiple sclerosis (MS) from those without the disease and provide information about MS-related clinical features, a study in China found. Using MRI scans, researchers created individualized maps of large brain networks and found widespread…
Discussion
Vitamin D supplementation did not consistently reduce relapse rates in adults with multiple sclerosis (MS), although it may reduce the number of MS lesions seen on MRI scans, according to a systematic review of published studies. Several trials found reductions in new or active lesions even when vitamin…
Get regular updates to your inbox.
